MyLab Module 31 Drugs for Coagulation Disorders 2026 Exam Questions and Answers | 20 Anticoagulant & Thrombolytic Nursing Practice Questions | Heparin, Warfarin, Alteplase & DVT Management

This detailed MyLab Module 31 Drugs for Coagulation Disorders 2026 exam study guide features 20 comprehensive nursing pharmacology and hematology practice questions with verified answers and clinical explanations focused on coagulation disorders, anticoagulants, antiplatelet therapy, thrombolytics, and bleeding risk management. The material is specifically designed to strengthen nursing students’ understanding of coagulation pathways, medication mechanisms of action, patient safety interventions, laboratory monitoring, and emergency management of anticoagulant-related complications commonly tested in nursing examinations and NCLEX-style assessments. Core pharmacologic and clinical topics covered include thrombolytics such as alteplase (Activase), anticoagulants including heparin, low-molecular-weight heparin (LMWH), warfarin (Coumadin), dabigatran (Pradaxa), and antiplatelet medications such as clopidogrel (Plavix). The document also explores protamine sulfate reversal therapy, idarucizumab (Praxbind), platelet aggregation, deep vein thrombosis (DVT), pulmonary embolism, myocardial infarction, stroke management, thrombocytopenia, liver disease-related bleeding disorders, and safe nursing interventions for patients receiving coagulation modifiers. Important nursing priorities such as bleeding assessment, monitoring for adverse effects, patient education, anticoagulant overlap therapy, and thromboembolic prevention are reinforced throughout the material. This resource is highly beneficial for Associate Degree Nursing (ADN), Bachelor of Science in Nursing (BSN), Practical Nursing (PN/LPN), and accelerated nursing students preparing for pharmacology, adult health nursing, medical-surgical nursing, hematology, or NCLEX-RN examinations. It is also valuable for nurse educators, ATI/MyLab remediation students, and healthcare trainees seeking additional practice with coagulation disorder medications and evidence-based anticoagulant nursing care. The study material aligns with current evidence-based nursing and pharmacology standards referenced in leading academic and clinical resources including Lehne’s Pharmacology for Nursing Care by Jacqueline Rosenjack Burchum and Laura D. Rosenthal, Brunner & Suddarth’s Textbook of Medical-Surgical Nursing, and recommendations from the American Heart Association (AHA), American Society of Hematology (ASH), and the Centers for Disease Control and Prevention (CDC). These authoritative references emphasize safe anticoagulant administration, prevention of thromboembolic complications, rapid recognition of hemorrhage, and appropriate use of reversal agents, all of which are highlighted throughout this document. Keywords MyLab Module 31, drugs for coagulation disorders, anticoagulants nursing, thrombolytics nursing, heparin therapy, warfarin nursing care, alteplase Activase, clopidogrel Plavix, dabigatran Pradaxa, protamine sulfate, idarucizumab Praxbind, DVT nursing care, pulmonary embolism treatment, platelet aggregation, thrombocytopenia, stroke pharmacology, myocardial infarction medications, anticoagulant reversal agents, coagulation modifiers, hematology nursing questions, NCLEX anticoagulants, nursing pharmacology exam, ATI pharmacology practice questions, medical surgical nursing, thromboembolic disorders